363 related articles for article (PubMed ID: 25456696)
1. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
Danson E; Bhindi R; Hansen P
Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
[No Abstract] [Full Text] [Related]
2. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography.
Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C
Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418
[No Abstract] [Full Text] [Related]
3. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
[No Abstract] [Full Text] [Related]
4. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
[No Abstract] [Full Text] [Related]
5. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
[No Abstract] [Full Text] [Related]
6. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
[No Abstract] [Full Text] [Related]
7. Complex coronary artery bifurcation treatment utilizing everolimus-eluting bioresorbable vascular scaffolds and optical coherence tomography.
Chan W; Shah A; Džavík V; Overgaard CB
Coron Artery Dis; 2014 Nov; 25(7):629-31. PubMed ID: 25248139
[No Abstract] [Full Text] [Related]
8. Proximal optimization technique and kissing balloon inflations with the bioresorbable vascular scaffold for coronary bifurcation percutaneous coronary intervention.
McGeoch RJ; Tanaka K; Overgaard CB; Bezerra HG; Džavík V
Can J Cardiol; 2014 Nov; 30(11):1461.e5-7. PubMed ID: 25442451
[TBL] [Abstract][Full Text] [Related]
9. Coronary spasm revascularized with a bioresorbable vascular scaffold.
Bil J; Pawlowski T; Gil RJ
Coron Artery Dis; 2015 Nov; 26(7):634-6. PubMed ID: 26267749
[No Abstract] [Full Text] [Related]
10. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
Opolski MP; Kepka C; Wojakowski W; Witkowski A
Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
[No Abstract] [Full Text] [Related]
11. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
Piraino D; Buccheri D; Andolina G
Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
[No Abstract] [Full Text] [Related]
12. "Golden tube" with favorable vessel remodeling at four-year follow-up after bioresorbable vascular scaffold implantation for moderate to severe calcified lesions: Insights from intravascular imaging.
Mitomo S; Candilio L; Tanaka A; Latib A; Colombo A
Cardiol J; 2018; 25(4):532-533. PubMed ID: 30211931
[No Abstract] [Full Text] [Related]
13. Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention.
Allahwala UK; Cockburn JA; Shaw E; Figtree GA; Hansen PS; Bhindi R
EuroIntervention; 2015 Feb; 10(10):1154-9. PubMed ID: 24647105
[TBL] [Abstract][Full Text] [Related]
14. Optical Coherence Tomography of Magnesium Bioresorbable Scaffold Restenosis.
García-Blas S; Miñana G; Sanchis J
Rev Esp Cardiol (Engl Ed); 2018 Dec; 71(12):1069. PubMed ID: 29223376
[No Abstract] [Full Text] [Related]
15. Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem.
Foin N; Lee R; Wong P; Low AF
EuroIntervention; 2015 Aug; 11(4):e1. PubMed ID: 26298237
[No Abstract] [Full Text] [Related]
16. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
17. Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".
Cortés C; Jaguszewski M; Schincariol M; Durán-Cortés MA; Limon U; Gutiérrez-Chico JL
Cardiol J; 2017; 24(6):700-701. PubMed ID: 29297580
[No Abstract] [Full Text] [Related]
18. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
19. [Complex coronary intervention with overlapping of bioresorbable scaffolds. Case report and new insights review in the use of bioresorbable vascular scaffolds guided by optical coherence tomography].
Macías E; Amador E
Arch Cardiol Mex; 2016; 86(2):170-4. PubMed ID: 26907194
[TBL] [Abstract][Full Text] [Related]
20. Bioresorbable Vascular Scaffolds in Coronary Bifurcation Lesions: Only in Expert Hands.
Colleran R; Byrne RA
Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):543-6. PubMed ID: 27157886
[No Abstract] [Full Text] [Related]
[Next] [New Search]
